With respect to esophageal cancer cells, it has been shown that TLR4 activation stimulates cell proliferation via the TLR4-MyD88-TRAF6-NF-κB signaling pathway and that inhibition of NF-κB leads to inhibition of proliferation [75]. Here, NFKB1 is linked to esophageal cancer.